|
Alex Stenzler is the Vice President of Advanced Technologies for VIASYS Respiratory Care Inc, a subsidiary of VIASYS Healthcare Corporation (NYSE-VAS) where he has worked since 1991. Mr. Stenzler brings more than thirty years of clinical and commercial experience in pulmonary medicine to his position. He started his career in the medical field as an Air Force aeromedical evacuation specialist during the Vietnam War and migrated into respiratory medicine as a Respiratory Therapist. Prior to joining VIASYS Respiratory Care, he was President of a respiratory research and development firm in New York and had directed Pulmonary Physiology Laboratories and Respiratory Care Departments in New York and Florida. Mr. Stenzler has been the principal investigator for two NIH studies and has served on the steering committees for randomized controlled trials in High Frequency Ventilation, Inhaled Nitric Oxide and Liquid Ventilation. Much of the research efforts that he has lead have been targeted at reducing the mortality and morbidity of premature infants and young children. Born and raised in New York City, Mr. Stenzler has also held several academic appointments, including Assistant Professor at the State University of New York at Stonybrook and twelve years in the Graduate School of Adelphi University. He did his undergraduate work at Queens College (City University of New York), has published numerous papers and abstracts and has been an invited speaker at many national and international congresses. He also holds more than a dozen US patents for various technologies. | 